FDCC
SEM

Foster Dykema Cabot & Co’s Select Medical SEM Stock Holding History

Foster Dykema Cabot & Co’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$6K Hold
447
– – ﹤0.01% 270
2023
Q2 		$8K Buy
+447
New +$6.93K ﹤0.01% 264

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Foster Dykema Cabot & Co's SEM Position: Q3 2023 in Review

Foster Dykema Cabot & Co held its Select Medical (SEM) position steady in Q3 2023 at 447 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #270.

Foster Dykema Cabot & Co first reported a position in SEM in Q2 2023 and has held it in 2 quarters since. The position peaked at $8K in Q2 2023. 247 funds tracked by Wall St. Rank hold SEM as of Q3 2023.

  • Foster Dykema Cabot & Co held 447 shares of Select Medical worth $6K as of Q3 2023.
  • Foster Dykema Cabot & Co left its Select Medical share count unchanged in Q3 2023.
  • Select Medical made up ﹤0.01% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #270 holding.
  • Foster Dykema Cabot & Co first reported a position in Select Medical in Q2 2023 and has held it in 2 quarters since.
  • Foster Dykema Cabot & Co's Select Medical position peaked at $8K in Q2 2023.
  • 247 funds tracked by Wall St. Rank held Select Medical as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.